<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1533" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1533/" /><meta name="ncbi_pagename" content="ELANE-Related Neutropenia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>ELANE-Related Neutropenia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="ELANE-Related Neutropenia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/08/23" /><meta name="citation_author" content="David C Dale" /><meta name="citation_author" content="Vahagn Makaryan" /><meta name="citation_pmid" content="20301705" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1533/" /><meta name="citation_keywords" content="Cyclic Neutropenia" /><meta name="citation_keywords" content="Congenital Neutropenia" /><meta name="citation_keywords" content="Neutrophil elastase" /><meta name="citation_keywords" content="ELANE" /><meta name="citation_keywords" content="ELANE-Related Neutropenia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="ELANE-Related Neutropenia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="David C Dale" /><meta name="DC.Contributor" content="Vahagn Makaryan" /><meta name="DC.Date" content="2018/08/23" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1533/" /><meta name="description" content="ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia." /><meta name="og:title" content="ELANE-Related Neutropenia" /><meta name="og:type" content="book" /><meta name="og:description" content="ELANE-related neutropenia includes congenital neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1533/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/cyclic-n/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1533/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8816FAE0410E2100000000014F007E.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1533_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1533_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/efemp2-cutis-laxa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/epb42-spherocytosis/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1533_"><span class="title" itemprop="name"><i>ELANE</i>-Related Neutropenia</span></h1><p class="contrib-group"><span itemprop="author">David C Dale</span>, MD and <span itemprop="author">Vahagn Makaryan</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1533_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1533_ai__"><div class="contrib half_rhythm"><span itemprop="author">David C Dale</span>, MD<div class="affiliation small">Professor, Department of Medicine<br />University of Washington Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@eladcd" class="oemail">ude.wu@eladcd</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Vahagn Makaryan</span>, MD<div class="affiliation small">Department of Medicine<br />University of Washington Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@mgahav" class="oemail">ude.wu@mgahav</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">June 17, 2002</span>; Last Update: <span itemprop="dateModified">August 23, 2018</span>.</p><p><em>Estimated reading time: 23 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="cyclic-n.Summary" itemprop="description"><h2 id="_cyclic-n_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>ELANE</i>-related neutropenia includes <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and cyclic neutropenia, both of which are primary hematologic disorders characterized by recurrent fever, skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, and pharyngitis), and cervical adenopathy. Infectious complications are generally more severe in congenital neutropenia than in cyclic neutropenia.</p><p>In <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia, omphalitis immediately after birth may be the first sign; in untreated children diarrhea, pneumonia, and deep abscesses in the liver, lungs, and subcutaneous tissues are common in the first year of life. After 15 years with granulocyte colony-stimulating factor treatment, the risk of developing myelodysplasia (MDS) or acute myelogenous leukemia (AML) is approximately 15%-25%.</p><p>Cyclic neutropenia is usually diagnosed within the first year of life based on approximately three-week intervals of fever and oral ulcerations and regular oscillations of blood cell counts. Cellulitis, especially perianal cellulitis, is common during neutropenic periods. Between neutropenic periods, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are generally healthy. Symptoms improve in adulthood. Cyclic neutropenia is not associated with risk of malignancy or conversion to leukemia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of <i>ELANE</i>-related neutropenia is established in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with suggestive clinical findings and the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ELANE</i> through <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> All fevers and infections require prompt evaluation and treatment. Abdominal pain requires evaluation for the potentially lethal complications of peritonitis and bacteremia. Immediate treatment with granulocyte colony-stimulating factor (G-CSF) and broad-spectrum antibiotics is important, even lifesaving, when an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has signs of serious infection, which may be caused by both aerobic and anaerobic pathogens.</p><p><i>Prevention of primary manifestations:</i> Treatment with G-CSF ameliorates symptoms and reduces infections in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Once absolute neutrophil count (ANC) levels normalize, resistance to infection greatly improves, such that affected individuals should be able to attend school, work, and recreational activities without specific concern. For affected individuals with a well-matched donor, hematopoietic stem cell transplantation (HSCT) may be the preferred treatment option. HSCT is the only alternative therapy for individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia who are refractory to high-dose G-CSF or who undergo malignant transformation.</p><p><i>Prevention of secondary complications:</i> Good dental hygiene; routine immunizations.</p><p><i>Surveillance:</i> Those with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia not undergoing HSCT require surveillance for malignant transformation to MDS/AML.</p><p><i>Agents/circumstances to avoid:</i> There is no need to avoid public places, as most infections are due to common organisms that occur on body surfaces.</p><p><i>Pregnancy management</i>: Pregnancies in women with severe chronic neutropenia are at substantial risk for miscarriage; treatment with G-CSF may reduce this risk.</p><p><i>Evaluation of relatives at risk:</i> Evaluate sibs and other at-risk relatives by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> to identify those with previously unrecognized mild or moderately severe disease who may benefit from treatment. Serial ANCs can also be used for evaluation of family members.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>ELANE</i>-related neutropenia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. One parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is usually <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. <i>De novo</i> pathogenic variants have been identified; their frequency is unknown. Each child of an individual with an <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has a 50% chance of inheriting the variant. Prenatal testing is possible for pregnancies at increased risk if the family-specific pathogenic variant is known.</p></div></div><div id="cyclic-n.GeneReview_Scope"><h2 id="_cyclic-n_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="cyclic-n.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1533/table/cyclic-n.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cyclic-n.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cyclic-n.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELANE</i>-Related Neutropenia: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_cyclic-n.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"><ul><li class="half_rhythm"><div>Congenital neutropenia</div></li><li class="half_rhythm"><div>Cyclic neutropenia</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#cyclic-n.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="cyclic-n.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#cyclic-n.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="cyclic-n.Diagnosis"><h2 id="_cyclic-n_Diagnosis_">Diagnosis</h2><p><i>ELANE</i>-related neutropenia represents a clinical spectrum that includes <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia, cyclic neutropenia, and intermediate findings between these two phenotypes. Identification of the precise clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is helpful for diagnosis, prognosis, and management.</p><div id="cyclic-n.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>ELANE</i>-related neutropenia <b>should be suspected</b> in individuals with the following clinical and supportive laboratory findings.</p><p><b>Clinical features</b></p><ul><li class="half_rhythm"><div><b>Severe or recurrent infections</b></div></li><li class="half_rhythm"><div><b>Congenital neutropenia.</b> Recurrent fevers, sinusitis, gingivitis, and chronic and severe infections in the lung, liver, and soft tissues occurring at irregular intervals</div></li><li class="half_rhythm"><div><b>Cyclic neutropenia</b></div><ul><li class="half_rhythm"><div>Mouth ulcers, pharyngitis, and fever recurring regularly at three-week intervals</div></li><li class="half_rhythm"><div>Inflammation and infection of the sinuses, upper- and lower-respiratory tract, and skin including the perianal area</div></li><li class="half_rhythm"><div>Abdominal pain and signs of an acute abdomen, suggesting sepsis and bacteremia from colonic ulcers</div></li></ul></li></ul><p><b>Supportive laboratory findings</b></p><ul><li class="half_rhythm"><div><b>Congenital neutropenia</b></div><ul><li class="half_rhythm"><div class="half_rhythm">At least three absolute neutrophil counts (ANCs) &#x0003c;500/&#x000b5;L obtained &#x02265;3 months after birth supports the diagnosis.</div><div class="half_rhythm">Note: The ANC is the white blood cell count (WBC) x % neutrophils.</div></li><li class="half_rhythm"><div class="half_rhythm">ANCs are &#x0003c;0.5x10<sup>9</sup>/L in most cases, and usually &#x0003c;0.2x10<sup>9</sup>/L; in one series, the mean ANC was 0.112x10<sup>9</sup>/L.</div></li><li class="half_rhythm"><div class="half_rhythm">In some individuals, periods with regular oscillations in blood neutrophil counts can be interspersed with periods in which no oscillations in blood neutrophil counts are apparent.</div></li><li class="half_rhythm"><div class="half_rhythm">Other hematopoietic cells</div><ul><li class="half_rhythm"><div>Monocyte counts tend to be increased (i.e., &#x0003e;1.0x10<sup>9</sup>/L).</div></li><li class="half_rhythm"><div>Platelet counts tend to be increased.</div></li><li class="half_rhythm"><div>Hematocrit tends to be mildly decreased.</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Bone marrow aspirate typically shows "maturation arrest" at the promyelocyte or myelocyte stage of neutrophil formation. Increased bone marrow monocytes and eosinophils may be present.</div></li><li class="half_rhythm"><div class="half_rhythm">Cytogenetic analysis of bone marrow is normal.</div></li></ul></li><li class="half_rhythm"><div><b>Cyclic neutropenia</b></div><ul><li class="half_rhythm"><div>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have an ANC &#x0003c;0.2x10<sup>9</sup>/L for three to five days at approximately three-week intervals.</div></li><li class="half_rhythm"><div>Oscillations of other cells, including lymphocytes, eosinophils, and platelets may be observed.</div></li><li class="half_rhythm"><div>Usually, a reciprocal increase in blood monocytes and reticulocytes occurs during the neutrophil nadir.</div></li><li class="half_rhythm"><div>Bone marrow aspirate shows an abnormality similar to that in <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia when neutrophil counts are the lowest; at other times, maturation of cells of the neutrophil lineage is near normal.</div></li></ul></li></ul><p>Note: (1) Cyclic neutropenia is distinguished from <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia by the regular oscillations of blood neutrophil counts in cyclic neutropenia. (2) Often, serial blood cell counts are needed to assure that individuals suspected of having congenital neutropenia do not have cyclic neutropenia; however, this approach has limitations because, in some cases of cyclic neutropenia, the amplitude of the oscillations may be very low.</p></div><div id="cyclic-n.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>A diagnostic algorithm for cyclic neutropenia has been published [<a class="bk_pop" href="#cyclic-n.REF.zeidler.2000.490">Zeidler et al 2000</a>].</p><p>The diagnosis of <i>ELANE</i>-related neutropenia <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ELANE</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1533/table/cyclic-n.T.molecular_genetic_testing_use/?report=objectonly" target="object" rid-figpopup="figcyclicnTmoleculargenetictestinguse" rid-ob="figobcyclicnTmoleculargenetictestinguse">Table 1</a>).</p><p>Note: The distinction between cyclic neutropenia and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia is primarily based on clinical findings and only secondarily on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> (see <a href="#cyclic-n.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>).</p><p>Molecular genetic testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> and use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>ELANE</i> is performed.</div><div class="half_rhythm">Note: Since the presumed mechanism of disease is production of abnormal enzyme that is not inhibited or packaged normally resulting in damage to cells of the neutrophil lineage during their development, testing for intragenic deletions or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> is unlikely to identify a disease-causing variant.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>ELANE</i> and other genes of interest (see <a href="#cyclic-n.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Pathogenic variants in more than one gene associated with neutropenia have been identified in some individuals [<a class="bk_pop" href="#cyclic-n.REF.germeshausen.2010.1207">Germeshausen et al 2010</a>], but the clinical significance of finding variants in two or more neutropenia-associated genes is not known. (3) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul><div id="cyclic-n.T.molecular_genetic_testing_use" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>ELANE</i>-Related Neutropenia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1533/table/cyclic-n.T.molecular_genetic_testing_use/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cyclic-n.T.molecular_genetic_testing_use_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELANE</i></td><td headers="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_cyclic-n.T.molecular_genetic_testing_use_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="cyclic-n.TF.1.1"><p class="no_margin">See <a href="/books/NBK1533/#cyclic-n.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="cyclic-n.TF.1.2"><p class="no_margin">See <a href="#cyclic-n.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="cyclic-n.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="cyclic-n.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#cyclic-n.REF.aprikyan.2002.209a">Aprikyan et al [2002]</a>, <a class="bk_pop" href="#cyclic-n.REF.ancliff.2003b.165">Ancliff et al [2003b]</a>, <a class="bk_pop" href="#cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot et al [2004]</a></p></div></dd><dt>5. </dt><dd><div id="cyclic-n.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="cyclic-n.TF.1.6"><p class="no_margin"><a class="bk_pop" href="#cyclic-n.REF.makaryan.2015.3">Makaryan et al [2015]</a></p></div></dd></dl></div></div></div></div></div><div id="cyclic-n.Clinical_Characteristics"><h2 id="_cyclic-n_Clinical_Characteristics_">Clinical Characteristics</h2><div id="cyclic-n.Clinical_Description"><h3>Clinical Description</h3><div id="cyclic-n.Congenital_Neutropenia"><h4>Congenital Neutropenia</h4><p>Infectious complications are generally more severe in <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia than in cyclic neutropenia. In both conditions, individuals have fever and recurrent skin and oropharyngeal inflammation (i.e., mouth ulcers, gingivitis, sinusitis, pharyngitis, and cervical adenopathy). In congenital neutropenia, diarrhea, pneumonia, and deep abscesses in the liver, lung, and subcutaneous tissues are common. Omphalitis immediately after birth may be the first sign [<a class="bk_pop" href="#cyclic-n.REF.dale.2017.351">Dale 2017</a>, <a class="bk_pop" href="#cyclic-n.REF.skokowa.2017.17032">Skokowa et al 2017</a>]. Bacteremia occurs infrequently but has severe consequences in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Most congenital neutropenia is diagnosed because of fever and severe infection in infants and young children.</p><p>Treatment with granulocyte colony-stimulating factor (G-CSF) raises blood neutrophil levels and reduces all of these complications in more than 90% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals [<a class="bk_pop" href="#cyclic-n.REF.dale.2017.351">Dale 2017</a>] (see <a href="#cyclic-n.Management">Management</a>).</p><p>Individuals with <i>ELANE-</i>related neutropenia are at risk of developing myelodysplasia syndrome (MDS) or acute myelogenous leukemia (AML). Myelodysplasia or leukemia typically arises gradually. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual may have a gradual loss in response to G-CSF treatment or what appears to be a minor change in blood cell counts. If there is neutropenia, infections are likely to occur. Anemia may lead to fatigue. Annual bone marrow examinations with <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> analysis are recommended for those treated with G-CSF. Chromosomal deletions, most commonly <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7, are predictors for leukemic evolution; however, there may be a very long lag period, even many years, between the discovery of monosomy 7 and MDS/AML. Similarly, acquired pathogenic variants in <i>CSF3R</i> (the G-CSF receptor) and <i>RUNX1</i> predict evolution to leukemia, but clinical tests for these findings are not widely available or necessary in clinical practice [<a class="bk_pop" href="#cyclic-n.REF.skokowa.2017.17032">Skokowa et al 2017</a>].</p><p>In a study conducted by <a class="bk_pop" href="#cyclic-n.REF.rosenberg.2008.210">Rosenberg et al [2008]</a> the cumulative incidence of MDS/AML 15 years after starting treatment with G-CSF was 36%. This finding is similar to the cumulative incidence of MDS/AML 15 years after starting treatment with G-CSF in individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia who do not have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ELANE</i> (25%; <i>P</i> = 0.96) [<a class="bk_pop" href="#cyclic-n.REF.rosenberg.2006.4628">Rosenberg et al 2006</a>]. Similarly, a prospective study of 374 persons with severe congenital neutropenia on long-term treatment with G-CSF showed that the overall risk of MDS/AML was 15%-25% at 15 years on treatment [<a class="bk_pop" href="#cyclic-n.REF.rosenberg.2010.196">Rosenberg et al 2010</a>], although this study did not distinguish between individuals with <i>ELANE</i>-related neutropenia and those with congenital neutropenia due to other causes. Overall, G-CSF reduced mortality from sepsis but uncovered an underlying disposition to MDS/AML. Individuals requiring higher doses of G-CSF (i.e., those requiring &#x0003e;8 &#x000b5;g/kg/day to achieve a mean neutrophil count equal to the group median [2.188x10<sup>9</sup>/L]) were at greater risk of death from both sepsis and MDS/AML than those responding to lower doses [<a class="bk_pop" href="#cyclic-n.REF.rosenberg.2010.196">Rosenberg et al 2010</a>, <a class="bk_pop" href="#cyclic-n.REF.makaryan.2015.3">Makaryan et al 2015</a>, <a class="bk_pop" href="#cyclic-n.REF.donadieu.2017.557">Donadieu et al 2017</a>].</p></div><div id="cyclic-n.Cyclic_Neutropenia"><h4>Cyclic Neutropenia</h4><p>Cyclic neutropenia is usually diagnosed soon after birth or within the first year of life based on a pattern of recurrent fever and oral ulcerations with serial blood cell counts showing regular oscillations. Peak neutrophil counts are usually &#x0003c;0.2x10<sup>9</sup>/L. Variations in this classic pattern include cycles longer or shorter than three weeks (probably &#x0003c;5% of individuals) and reduced amplitude of oscillations. Counts in children tend to oscillate more obviously than in adults.</p><p>Untreated individuals have recurrent oropharyngeal inflammation; they are particularly prone to developing oral ulcers at approximately three-week intervals. Cellulitis, especially perianal cellulitis, is common during the neutropenic periods. Bacteremia is rare; the greatest risk appears to be for death from necrotizing enterocolitis, peritonitis, and <i>Clostridium</i> and/or <i>E coli</i> sepsis [<a class="bk_pop" href="#cyclic-n.REF.barnes.2004.e757">Barnes et al 2004</a>].</p><p>Symptoms tend to be more severe in children than in adults. <a class="bk_pop" href="#cyclic-n.REF.palmer.1996.413">Palmer et al [1996]</a> reported that more than 60% of individuals with cyclic neutropenia experience oral ulcerations, gingivitis, lymphadenopathy, fever, pharyngitis/tonsillitis, fatigue, or skin infections five or more times a year. More than 30% of adults report five or more episodes per year of sinusitis and/or otitis media, and more than 20% of children report at least five episodes per year of bone pain or tooth abscesses. More than 10% of individuals report pneumonia, bronchitis, diarrhea, or anal ulcers. Serious neonatal infections and sepsis are rare.</p><p>Between neutropenic periods, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are generally healthy.</p><p>Symptoms improve in adulthood. Skin infections, fever, lymphadenopathy, and pharyngitis occur less frequently. Sinusitis, headache, and bone pain remain the most common symptoms. Oral ulcers, fatigue, and gingivitis also occur frequently. Permanent tooth loss resulting from chronic gingivitis, tooth abscesses, and alveolar bone loss in adolescence or young adulthood is common.</p><p>There are no associated <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> abnormalities. Cyclic phenomena in other organ systems have not been recognized, probably because <i>ELANE</i> is expressed only in myeloid cells.</p><p>Cyclic neutropenia is not associated with an increased risk of malignancy or conversion to leukemia. However, confusion may arise when the series of counts is insufficient to clearly determine if an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> or cyclic neutropenia.</p></div><div id="cyclic-n.Intermediate_Phenotypes"><h4>Intermediate Phenotypes</h4><p>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may at times have an obvious cyclic pattern of fluctuations in the neutrophil counts and at other times have counts that do not cycle, so that the diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia seems appropriate. In families with multiple affected members in the same generation, one person may appear to have cyclic neutropenia while another has features more consistent with congenital neutropenia [<a class="bk_pop" href="#cyclic-n.REF.newburger.2010.314">Newburger et al 2010</a>]. Cycling confers a favorable prognosis: better response to G-CSF and a lower risk of MDS/AML [<a class="bk_pop" href="#cyclic-n.REF.makaryan.2015.3">Makaryan et al 2015</a>, <a class="bk_pop" href="#cyclic-n.REF.dale.2017.2290">Dale et al 2017</a>].</p></div></div><div id="cyclic-n.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlations are only roughly defined for <i>ELANE</i>-related neutropenia. Although the patterns of pathogenic variants in <i>ELANE</i>-associated cyclic neutropenia and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia are distinct on a population basis, the patterns of pathogenic variants do overlap, indicating that the distinction between cyclic neutropenia and congenital neutropenia is primarily based on clinical findings and only secondarily on <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> [<a class="bk_pop" href="#cyclic-n.REF.dale.2017.351">Dale 2017</a>, <a class="bk_pop" href="#cyclic-n.REF.skokowa.2017.17032">Skokowa et al 2017</a>]. <a class="bk_pop" href="#cyclic-n.REF.newburger.2010.314">Newburger et al [2010]</a> identified individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> who had different clinical phenotypes.</p><p>The risk of developing myelodysplasia or acute myelogenous leukemia varies considerably depending on the specific <i>ELANE</i> variant [<a class="bk_pop" href="#cyclic-n.REF.makaryan.2015.3">Makaryan et al 2015</a>]. The full scope of <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> variation is not yet known, but the pathogenic variants <a class="figpopup" href="/books/NBK1533/table/cyclic-n.T.selected_elane_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figcyclicnTselectedelanepathogenicvar" rid-ob="figobcyclicnTselectedelanepathogenicvar">p.Cys151Tyr</a> and <a class="figpopup" href="/books/NBK1533/table/cyclic-n.T.selected_elane_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figcyclicnTselectedelanepathogenicvar" rid-ob="figobcyclicnTselectedelanepathogenicvar">p.Gly214Arg</a> variants are associated with a poor prognosis and the pathogenic variants <a class="figpopup" href="/books/NBK1533/table/cyclic-n.T.selected_elane_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figcyclicnTselectedelanepathogenicvar" rid-ob="figobcyclicnTselectedelanepathogenicvar">p.Ser126Leu</a> and <a class="figpopup" href="/books/NBK1533/table/cyclic-n.T.selected_elane_pathogenic_var/?report=objectonly" target="object" rid-figpopup="figcyclicnTselectedelanepathogenicvar" rid-ob="figobcyclicnTselectedelanepathogenicvar">p.Pro139Leu</a> with a good prognosis.</p><p>Some <i>ELANE</i> pathogenic variants now appear to be exclusively or almost exclusively associated with cyclic neutropenia and no recognized risk of evolution to acute myelogenous leukemia (AML), whereas other pathogenic variants may be associated with severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and increased risk of AML [<a class="bk_pop" href="#cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot et al 2004</a>, <a class="bk_pop" href="#cyclic-n.REF.makaryan.2015.3">Makaryan et al 2015</a>]. At present it is not known how variations in the mutated protein affect the severity of neutropenia or the risk of AML.</p></div><div id="cyclic-n.Nomenclature"><h3>Nomenclature</h3><p>Prior to the discovery of the different genetic causes of severe chronic neutropenia, the term "Kostmann syndrome" was used to refer to individuals with severe chronic neutropenia. The original family reported by Kostmann was found to have bialleic pathogenic variants in <i>HAX1</i> inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> fashion. However, one individual in a kindred originally described by Kostmann as having Kostmann syndrome was identified to have a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>ELANE</i> [<a class="bk_pop" href="#cyclic-n.REF.zeidler.2002.82">Zeidler &#x00026; Welte 2002</a>, <a class="bk_pop" href="#cyclic-n.REF.carlsson.2006.589">Carlsson et al 2006</a>] (see <a href="#cyclic-n.Differential_Diagnosis">Differential Diagnosis</a>).</p></div><div id="cyclic-n.Prevalence"><h3>Prevalence</h3><p>Congenital neutropenia has an estimated frequency of 2:1,000,000-3:1,000,000 in the general population.</p><p>Cyclic neutropenia has an estimated frequency of 1:1,000,000 in the general population, including both <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> cases and <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., single occurrences in a family).</p><p><i>ELANE</i>-related neutropenia is the most common cause of chronic neutropenia in children, although the precise prevalence of <i>ELANE</i>-related neutropenia is unknown.</p></div></div><div id="cyclic-n.Genetically_Related_Allelic_Dis"><h2 id="_cyclic-n_Genetically_Related_Allelic_Dis_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>ELANE</i>.</p></div><div id="cyclic-n.Differential_Diagnosis"><h2 id="_cyclic-n_Differential_Diagnosis_">Differential Diagnosis</h2><div id="cyclic-n.Congenital_Neutropenia_1"><h3>Congenital Neutropenia</h3><p>The differential diagnosis of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia includes the following disorders.</p><p><b>Isolated neutropenia</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Kostmann disease (OMIM <a href="https://omim.org/entry/610738" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">610738</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>HAX1</i> [<a class="bk_pop" href="#cyclic-n.REF.klein.2007.86">Klein et al 2007</a>]</div><div class="half_rhythm">Note: <i>De novo</i> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>ELANE</i> pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia) are much more common than <i>HAX1</i> pathogenic variants (<a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> congenital neutropenia) as a cause of <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases of severe congenital neutropenia (i.e., a single occurrence in a family) [<a class="bk_pop" href="#cyclic-n.REF.xia.2009.535">Xia et al 2009</a>]. For this reason, it is usually best to first sequence <i>ELANE</i> in seeking to determine the genetic basis for severe congenital neutropenia.</div></li><li class="half_rhythm"><div class="half_rhythm">Nonsyndromic severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia due to G6PC3 deficiency, an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of severe congenital neutropenia caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>G6PC3</i> (see <a href="/books/n/gene/g6pc3-def/">G6PC3 Deficiency</a>)</div></li><li class="half_rhythm"><div class="half_rhythm"><i>GFI1</i>-related severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia. A <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GFI1</i> was reported in one person with severe congenital neutropenia [<a class="bk_pop" href="#cyclic-n.REF.person.2003.308">Person et al 2003</a>].</div></li><li class="half_rhythm"><div class="half_rhythm">Benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> neutropenia (OMIM <a href="https://www.omim.org/entry/162700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">162700</a>), an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> form of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia with milder neutropenia and less severe symptoms</div></li><li class="half_rhythm"><div class="half_rhythm">Benign ethnic neutropenia associated with the Duffy <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a> (Duffy antigen receptor for chemokines or DARC-null genotype) is a common cause of neutropenia in persons of African heritage [<a class="bk_pop" href="#cyclic-n.REF.thobakgale.2014.50">Thobakgale &#x00026; Ndung'u 2014</a>]. This condition is caused by <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> pathogenic variants in <i>ACKR1</i> and is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> fashion.</div></li><li class="half_rhythm"><div class="half_rhythm">Autoimmune neutropenia, usually attributed to anti-neutrophil antibodies</div></li><li class="half_rhythm"><div class="half_rhythm">Idiopathic neutropenia (<a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> neutropenia of unknown cause)</div></li><li class="half_rhythm"><div class="half_rhythm">Cyclic neutropenia</div></li></ul><p><b>Selected syndromes with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia</b> (see <a class="bk_pop" href="#cyclic-n.REF.klein.2011.399">Klein [2011]</a>)</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/gsd1/">Glycogen storage disease type Ib</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/sds/">Shwachman-Diamond syndrome</a></div></li><li class="half_rhythm"><div>Reticular dysgenesis (OMIM <a href="https://omim.org/entry/267500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">267500</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/chh/">Cartilage-hair hypoplasia</a></div></li><li class="half_rhythm"><div><a href="/books/n/gene/chediak-higashi/">Chediak-Higashi syndrome</a></div></li><li class="half_rhythm"><div>Griscelli syndrome (OMIM <a href="https://www.omim.org/phenotypicSeries/PS214450" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PS214450</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/barth/">Barth syndrome</a></div></li><li class="half_rhythm"><div>Wiskott-Aldrich syndrome (see <a href="/books/n/gene/was/"><i>WAS</i>-Related Disorders</a>)</div></li><li class="half_rhythm"><div><a href="/books/n/gene/dkc/">Dyskeratosis congenita</a></div></li><li class="half_rhythm"><div>Myelokathexis (WHIM syndrome; OMIM <a href="https://www.omim.org/entry/193670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">193670</a>)</div></li><li class="half_rhythm"><div>Classic G6PC3 deficiency (severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia type 4) (see <a href="/books/n/gene/g6pc3-def/">G6PC3 Deficiency</a>)</div></li></ul></div><div id="cyclic-n.Cyclic_Neutropenia_1"><h3>Cyclic Neutropenia</h3><p>Other diagnoses confused with cyclic neutropenia include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>, autoimmune, and benign neutropenia of childhood.</p></div><div id="cyclic-n.Fever"><h3>Fever</h3><p>Other disorders with recurrent fevers are <a href="/books/n/gene/fmf/">familial Mediterranean fever</a> and PFAPA (<i>p</i>eriodic <i>f</i>ever, <i>a</i>denopathy, <i>p</i>haryngitis, and <i>a</i>phthous ulcers).</p></div></div><div id="cyclic-n.Management"><h2 id="_cyclic-n_Management_">Management</h2><div id="cyclic-n.Evaluations_Following_Initial_D"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease in an individual diagnosed with <i>ELANE</i>-related neutropenia, the following are recommended if they have not already been completed:</p><ul><li class="half_rhythm"><div>Dental examination for gingival and periodontal disease</div></li><li class="half_rhythm"><div>Evaluation (particularly of those with severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia) by an otolaryngologist and a pulmonologist for chronic sinopulmonary inflammation and deep abscesses</div></li><li class="half_rhythm"><div>Evaluation of individuals with severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia for evidence of myelodysplasia or leukemia with bone marrow aspirate and biopsy</div></li><li class="half_rhythm"><div>Consultation with a clinical hematologist, geneticist, and/or genetic counselor for specific clinical advice</div></li></ul></div><div id="cyclic-n.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Fevers</b> require prompt evaluation and empiric treatment until the source of the fever can be definitively identified, at which time targeted treatment may be possible:</p><ul><li class="half_rhythm"><div>Initiation of broad-spectrum antibiotics is important, even lifesaving, when an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual has signs of serious infection, which may be caused by either aerobic or anaerobic pathogens. Coverage matching local patterns for infections in immunosuppressed individuals should initially be given for both aerobic and anaerobic organisms.</div></li><li class="half_rhythm"><div>Granulocyte colony-stimulating factor (G-CSF), given subcutaneously, should also be administered daily starting immediately to promote increased neutrophil production and deployment.</div></li></ul><p><b>Fever with abdominal pain</b> is potentially life threatening due to the risk for peritonitis from a perforated colonic ulcer. Surgical evaluation by physical examination and (as needed) imaging studies is indicated.</p></div><div id="cyclic-n.Prevention_of_Primary_Manifesta"><h3>Prevention of Primary Manifestations</h3><p><b>Granulocyte colony-stimulating factor (G-CSF).</b> Treatment with G-CSF is effective in elevating blood neutrophil counts in both <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and cyclic neutropenia. G-CSF treatment ameliorates the symptoms and problems of infections in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. (Although both G-CSF and granulocyte-macrophage (GM)-CSF have been used to treat <i>ELANE</i>-related neutropenia, G-CSF is much more effective and associated with fewer adverse effects than GM-CSF.)</p><p>In cyclic neutropenia, G-CSF shortens the periods of neutropenia as well as the length of the neutropenic cycle. Treatment is known to be effective at least as early as age six months to one year. Studies indicate that treatment is effective with no adverse effects on growth, development, or pregnancy outcome with follow up to age 18 years [<a class="bk_pop" href="#cyclic-n.REF.dale.2017.2290">Dale et al 2017</a>].</p><p>Treatment of cyclic neutropenia requires daily or alternate-day injections of G-CSF, normally in a dose of ~2 &#x000b5;g/kg/day. Individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia often require higher doses (e.g., 5-10 &#x000b5;g/kg/day).</p><p>Common side effects of G-CSF include bone pain, headache, splenomegaly, and osteoporosis. Vasculitis, rashes, arthralgias, and glomerulonephritis have been infrequently reported [<a class="bk_pop" href="#cyclic-n.REF.dale.2003.82">Dale et al 2003</a>].</p><p>Note: (1) When <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are given G-CSF and their ANC normalizes, their resistance to infection improves greatly. They should be able to attend school, work, and engage in recreational activities without specific concerns; (2) G-CSF treatment is associated with mild increases in the size of the spleen, but this is very rarely, if ever, a cause for specific concern in those with <i>ELANE</i>-related neutropenia.</p><p><b>Hematopoietic stem cell transplantation (HSCT)</b></p><ul><li class="half_rhythm"><div>For <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with a well-matched donor, HSCT may be the preferred treatment option [<a class="bk_pop" href="#cyclic-n.REF.choi.2010.937">Choi &#x00026; Levine 2010</a>, <a class="bk_pop" href="#cyclic-n.REF.oshima.2010.657">Oshima et al 2010</a>, <a class="bk_pop" href="#cyclic-n.REF.connelly.2012.44">Connelly et al 2012</a>, <a class="bk_pop" href="#cyclic-n.REF.fioredda.2015.1885">Fioredda et al 2015</a>].</div></li><li class="half_rhythm"><div>HSCT is the only alternative therapy for individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia who are refractory to high-dose G-CSF or who undergo malignant transformation.</div></li></ul></div><div id="cyclic-n.Prevention_of_Secondary_Complic"><h3>Prevention of Secondary Complications</h3><p>Good dental hygiene with regular hygiene visits (several times per year) and careful brushing and flossing are recommended.</p><p>Individuals with <i>ELANE</i>-associated neutropenia are susceptible to common viral infections that may be complicated by bacterial infections, such as pneumonia due to bacteria commonly found in the upper respiratory tract. Such individuals respond well to immunizations to protect them from viral and bacterial infections. They should be given all routine vaccines.</p></div><div id="cyclic-n.Surveillance"><h3>Surveillance</h3><p>For those individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia not undergoing HSCT, surveillance for evidence of malignant transformation to MDS/AML is critical to allow early therapeutic intervention. Observation should include the following:</p><ul><li class="half_rhythm"><div>General evaluations by parents and medical personnel several times a year</div></li><li class="half_rhythm"><div>Blood counts several times a year</div></li><li class="half_rhythm"><div>Annual bone marrow <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> studies because of the frequent association of <a class="def" href="/books/n/gene/glossary/def-item/monosomy/">monosomy</a> 7 and malignant transformation</div></li></ul><p>Note: Although sequencing of the receptor for G-CSF (<i>CSF3R</i>) from peripheral blood may also provide evidence of evolution to MDS/AML [<a class="bk_pop" href="#cyclic-n.REF.ancliff.2003a.685">Ancliff et al 2003a</a>], its clinical utility is not yet clearly established [<a class="bk_pop" href="#cyclic-n.REF.touw.2015.1">Touw 2015</a>, <a class="bk_pop" href="#cyclic-n.REF.skokowa.2017.17032">Skokowa et al 2017</a>].</p></div><div id="cyclic-n.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Most infections are caused by common organisms on body surfaces including <i>Clostridia</i> species and other anaerobes in the intestinal biota. For this reason it is of little or no benefit to avoid public places.</p></div><div id="cyclic-n.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Evaluation of sibs and other at-risk relatives by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> identifies those with previously unrecognized mild or moderately severe disease who may benefit from treatment. Serial ANCs can also be used for evaluation of family members.</p><p>Note: Relatives of individuals with typical cycles may have neutropenia but lack obvious cycles.</p><p>Treatment of these individuals with G-CSF or any other modality should be based on medical history and the severity of symptoms. It is not yet clear if there are specific risks (i.e., osteoporosis, myelodysplasia, or leukemia) associated with administering G-CSF to such individuals, but conservative management is recommended.</p><p>See <a href="#cyclic-n.Related_Genetic_Counseling_Issu">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="cyclic-n.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancies in women with severe chronic neutropenia are at substantial risk for miscarriage.</p><p>A review of the records of 88 women (183 pregnancies) with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a>, cyclic, <a class="def" href="/books/n/gene/glossary/def-item/idiopathic/">idiopathic</a>, or autoimmune neutropenia compared outcomes in those on G-CSF therapy during pregnancy with those not on G-CSF therapy during pregnancy [<a class="bk_pop" href="#cyclic-n.REF.boxer.2015.197">Boxer et al 2015</a>]. Of these 88 women, 44 had congenital or cyclic neutropenia &#x02013; accounting for 95 of the 183 pregnancies. Although genetic testing results were not reported, it is likely that at least half of the 44 women had <i>ELANE</i>-related neutropenia. In general the health of all the infants was equivalent for the two groups. Other findings included the following:</p><ul><li class="half_rhythm"><div>Reduced risk of fetal loss in the women treated during pregnancy</div></li><li class="half_rhythm"><div>Among 55 women (123 pregnancies) not treated with G-CSF during pregnancy: 11 complications (1 premature rupture of membranes, 2 life-threatening infections, 2 minor infections, and 6 premature labors)</div></li><li class="half_rhythm"><div>Among 41 women (60 pregnancies) treated with G-CSF during pregnancy: no life-threatening infections, no premature labors, five minor infections, and one woman who developed severe thrombocytopenia</div></li></ul><p>See <a href="http://www.mothertobaby.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">MotherToBaby</a> for further information on medication use during pregnancy.</p></div><div id="cyclic-n.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Unrelated cord blood transplantation for neutropenia is being investigated; outcome appears to depend on the closeness of the match [<a class="bk_pop" href="#cyclic-n.REF.connelly.2012.44">Connelly et al 2012</a>, <a class="bk_pop" href="#cyclic-n.REF.fioredda.2015.1885">Fioredda et al 2015</a>].</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions.</p></div></div><div id="cyclic-n.Genetic_Counseling"><h2 id="_cyclic-n_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="cyclic-n.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>ELANE</i>-related neutropenia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="cyclic-n.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Many individuals diagnosed with <i>ELANE</i>-related neutropenia have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Some individuals diagnosed with <i>ELANE</i>-related neutropenia have the disorder as the result of a <i>de novo ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. <i>De novo</i> pathogenic variants have been identified [<a class="bk_pop" href="#cyclic-n.REF.horwitz.1999.433">Horwitz et al 1999</a>, <a class="bk_pop" href="#cyclic-n.REF.aprikyan.2002.209a">Aprikyan et al 2002</a>]; their frequency is unknown.</div></li><li class="half_rhythm"><div>If neither parent is known to be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of the parents for the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended. Parents may also be evaluated with complete blood counts (CBCs) obtained weekly for a month until an ANC &#x0003c;0.2x10<sup>9</sup>/L is documented in more than one sample.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent [<a class="bk_pop" href="#cyclic-n.REF.newburger.2010.314">Newburger et al 2010</a>].</div></li><li class="half_rhythm"><div>Note: The family history may appear to be negative because of failure to diagnose the disorder in a mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; for example, if the parent is the individual in whom a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally affected.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to sibs is 50%.</div></li><li class="half_rhythm"><div>If the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is estimated to be 1% because of the theoretic possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#cyclic-n.REF.rahbari.2016.126">Rahbari et al 2016</a>].</div></li></ul></li><li class="half_rhythm"><div>If the parents have not been tested for the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> but are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low; however, parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> remains a possibility.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with <i>ELANE</i>-related neutropenia has a 50% chance of inheriting the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent has the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members are at risk.</p></div><div id="cyclic-n.Related_Genetic_Counseling_Issu"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#cyclic-n.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <i>de novo</i> pathogenic variant. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. Multiple cases of <i>ELANE</i>-related neutropenia have occurred via sperm donation from a single donor [<a class="bk_pop" href="#cyclic-n.REF.boxer.2006.633">Boxer et al 2006</a>].</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="cyclic-n.Prenatal_Testing_and_Preimplant"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>ELANE</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="cyclic-n.Resources"><h2 id="_cyclic-n_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>National Neutropenia Network: North America Patient and Family Support Group</b></div><div>PO Box 1693</div><div>Brighton MI 48116</div><div><b>Phone:</b> 877-326-7117</div><div><b>Email:</b> kate@neutropenianet.org</div><div><a href="https://www.neutropenianet.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.neutropenianet.org</a></div></li><li class="half_rhythm"><div><b>Neutropenia Support Association Inc.: Canada Patient and Family Support Group </b></div><div>971 Corydon Avenue</div><div>P.O. Box 243</div><div>Winnipeg Manitoba R3M 3SR</div><div>Canada</div><div><b>Phone:</b> 204-489-8454; 800-663-8876 (within Canada and U.S.)</div><div><b>Email:</b> stevensl@neutropenia.ca</div><div><a href="https://www.neutropenia.ca/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.neutropenia.ca</a></div></li><li class="half_rhythm"><div><b>European Society for Immunodeficiencies (ESID) Registry</b></div><div>Dr. Gerhard Kindle</div><div>University Medical Center Freiburg Centre of Chronic Immunodeficiency</div><div>Engesserstr. 4</div><div>79106 Freiburg </div><div>Germany</div><div><b>Phone:</b> 49-761-270-34450</div><div><b>Email:</b> esid-registry@uniklinik-freiburg.de</div><div><a href="http://esid.org/Working-Parties/Registry" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ESID Registry</a></div></li><li class="half_rhythm"><div><b>National Cancer Institute Inherited Bone Marrow Failure Syndromes (IBMFS) Cohort Registry</b></div><div><b>Phone:</b> 800-518-8474</div><div><b>Email:</b> NCI.IBMFS@westat.com</div><div><a href="https://www.marrowfailure.cancer.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.marrowfailure.cancer.gov</a></div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: Australia, India, and Southeast Asia</b></div><div>St. Vincent&#x02019;s Hospital, Department of Medicine</div><div>Fitzroy Victoria 3065</div><div>Australia</div><div><b>Phone:</b> 61-3-9231-2574</div><div><b>Email:</b> ffirkin@bigpond.net.au</div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: Europe, Africa, and Middle East</b></div><div>Carl-Neuberg-Str., 30625</div><div>Hannover </div><div>Germany</div><div><b>Phone:</b> 49-511-546-0918</div><div><b>Fax:</b> 49-511-557-106</div><div><b>Email:</b> zeidler.cornelia@mh-hannover.de</div><div><a href="http://www.severe-chronic-neutropenia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Severe Chronic Neutropenia International Registry Hannover</a></div></li><li class="half_rhythm"><div><b>Severe Chronic Neutropenia International Registry: North and South America</b></div><div>1107 Northeast 45th Street</div><div>Suite 345</div><div>Seattle WA 98105</div><div><b>Phone:</b> 206-543-9749; 800-726-4463 (within U.S.)</div><div><b>Fax:</b> 206-543-3668</div><div><b>Email:</b> bolyard@uw.edu</div><div><a href="https://depts.washington.edu/registry/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Severe Chronic Neutropenia International Registry Seattle</a></div></li></ul></div><div id="cyclic-n.Molecular_Genetics"><h2 id="_cyclic-n_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="cyclic-n.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>ELANE-Related Neutropenia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1533/table/cyclic-n.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cyclic-n.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_cyclic-n.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_cyclic-n.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_cyclic-n.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_cyclic-n.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_cyclic-n.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_cyclic-n.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/1991" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ELANE</i></a></td><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=1991" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">19p13<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P08246" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Neutrophil elastase</a></td><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://research.cchmc.org/LOVD2/home.php?select_db=ELANE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CCHMC - Human Genetics Mutation Database (ELANE)</a><br /><a href="http://structure.bmc.lu.se/idbase/ELA2base/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ELA2base: Mutation registry for Cyclic and congenital neutropenia (ELANE)</a></td><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ELANE" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ELANE</a></td><td headers="hd_b_cyclic-n.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ELANE[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ELANE</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="cyclic-n.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="cyclic-n.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for ELANE-Related Neutropenia (<a href="/omim/130130,162800,202700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1533/table/cyclic-n.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cyclic-n.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/130130" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">130130</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ELASTASE, NEUTROPHIL-EXPRESSED; ELANE</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/162800" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">162800</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CYCLIC NEUTROPENIA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/202700" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">202700</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1</td></tr></tbody></table></div></div><div id="cyclic-n.Molecular_Genetic_Pathogenesis"><h3>Molecular Genetic Pathogenesis</h3><p>Neutrophils are an essential part of the innate immune system and, therefore, are required to produce enzymes that are cytotoxic by nature. <i>ELANE</i> encodes leukocyte elastase (or neutrophil elastase), which is packaged into neutrophil granules as fully active enzyme. The cell is normally protected from damaging enzyme activity by the terminal peptides that are cleaved just before packaging; however, in <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and cyclic neutropenia, the abnormal enzyme is not inhibited or packaged normally and, therefore, damages cells of the neutrophil lineage during their development.</p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises five exons. For a detailed summary of gene and protein information, see <a href="/books/NBK1533/#cyclic-n.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b>
<i>ELANE</i> pathogenic variants include <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, small deletions/insertions in exons, <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> defects, and changes in 5' regulatory region. In one study, 104 of 125 individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia had 18 different pathogenic variants and 94 of 105 probands with cyclic neutropenia were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for seven different pathogenic variants [<a class="bk_pop" href="#cyclic-n.REF.aprikyan.2002.209a">Aprikyan et al 2002</a>]. Other studies have generally reported a somewhat lower frequency, the variations probably depending on the pre-test identification and selection of cases.</p><div id="cyclic-n.T.selected_elane_pathogenic_var" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Selected <i>ELANE</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1533/table/cyclic-n.T.selected_elane_pathogenic_var/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__cyclic-n.T.selected_elane_pathogenic_var_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.211T&#x0003e;C</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys71Arg</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_3" rowspan="5" colspan="1" style="text-align:left;vertical-align:middle;"><a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001972.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001972<wbr style="display:inline-block"></wbr>​.2</a><br /><a href="https://www.ncbi.nlm.nih.gov/protein/NP_001963.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001963<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.377C&#x0003e;T</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser126Leu</td></tr><tr><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.416C&#x0003e;T</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Pro139Leu</td></tr><tr><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.452G&#x0003e;A</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Cys151Tyr</td></tr><tr><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.640G&#x0003e;C</td><td headers="hd_h_cyclic-n.T.selected_elane_pathogenic_var_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly214Arg</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>ELANE</i> encodes leukocyte elastase (also called neutrophil elastase), a 240-amino-acid protein with broad proteolytic activities, which is processed into a 238-amino-acid mature protein. Leukocyte elastase, produced by neutrophil precursors, is an early developmental feature of the neutrophil's primary granules. The enzyme is processed in the Golgi apparatus and packaged into the granules as fully active enzyme [<a class="bk_pop" href="#cyclic-n.REF.garwicz.2005.38">Garwicz et al 2005</a>]. The cell is normally protected from damaging enzyme activity by the terminal peptides that are cleaved just before packaging.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> It is hypothesized that in <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia and cyclic neutropenia the abnormal enzyme is not inhibited or packaged normally and, therefore, damages cells of the neutrophil lineage during their development.</p><p>A natural experiment has provided compelling evidence that pathogenic variants in <i>ELANE</i> result in the destruction of neutrophils before they can enter circulation. The father of an individual with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia was found to be mosaic for a c.211T&#x0003e;C (p.Cys71Arg) <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; half of his somatic cells tested contained the abnormal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, but it was virtually absent in circulating neutrophils [<a class="bk_pop" href="#cyclic-n.REF.ancliff.2002.707">Ancliff et al 2002</a>].</p><p>Cellular studies on pathogenesis of cyclic neutropenia have clearly demonstrated that accelerated apoptosis of neutrophil precursors is the proximate cause of the reduced neutrophil production. The oscillation of blood counts in cyclic neutropenia is attributed to the excessive cell turnover in the early neutrophil compartments, coupled to a system of long-range regulation by feedback from peripheral tissues [<a class="bk_pop" href="#cyclic-n.REF.haurie.1998.2629">Haurie et al 1998</a>]. The accelerated apoptosis may be mediated by altered expression of pro-apoptotic factors, Bcl-2, or cytoplasmic accumulation and induction of the unfolding protein response [<a class="bk_pop" href="#cyclic-n.REF.papadaki.2003.447">Papadaki &#x00026; Eliopoulos 2003</a>, <a class="bk_pop" href="#cyclic-n.REF.carlsson.2004.3355">Carlsson et al 2004</a>, <a class="bk_pop" href="#cyclic-n.REF.massullo.2005.3397">Massullo et al 2005</a>, <a class="bk_pop" href="#cyclic-n.REF.k_llner.2006.493">K&#x000f6;llner et al 2006</a>, <a class="bk_pop" href="#cyclic-n.REF.skokowa.2017.17032">Skokowa et al 2017</a>].</p></div></div><div id="cyclic-n.References"><h2 id="_cyclic-n_References_">References</h2><div id="cyclic-n.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.ancliff.2003a.685">Ancliff PJ, Gale RE, Liesner R, Hann I, Linch DC. Long-term follow-up of granulocyte colony-stimulating factor receptor mutations in patients with severe congenital neutropenia: implications for leukaemogenesis and therapy. <span><span class="ref-journal">Br J Haematol. </span>2003a;<span class="ref-vol">120</span>:685–90.</span> [<a href="/pubmed/12588357" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12588357</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.ancliff.2003b.165">Ancliff PJ, Gale RE, Linch DC. Neutrophil elastase mutations in congenital neutropenia. <span><span class="ref-journal">Hematology. </span>2003b;<span class="ref-vol">8</span>:165–71.</span> [<a href="/pubmed/12745650" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12745650</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.ancliff.2002.707">Ancliff PJ, Gale RE, Watts MJ, Liesner R, Hann IM, Strobel S, Linch DC. Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">100</span>:707–9.</span> [<a href="/pubmed/12091371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12091371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.aprikyan.2002.209a">Aprikyan AG, Stein S, Kutyavin T, Rodger E, Bolyard AA, Dale DC. The causal role of mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. <span><span class="ref-journal">Soc Exp Hematol. </span>2002;<span class="ref-vol">30</span>:209a.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.barnes.2004.e757">Barnes C, Gerstle JT, Freedman MH, Carcao MD. Clostridium septicum myonecrosis in congenital neutropenia. <span><span class="ref-journal">Pediatrics. </span>2004;<span class="ref-vol">114</span>:e757–60.</span> [<a href="/pubmed/15574607" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15574607</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.bellann_chantelot.2004.4119">Bellann&#x000e9;-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:4119–25.</span> [<a href="/pubmed/14962902" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14962902</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.boxer.2015.197">Boxer LA, Bolyard AA, Kelley ML, Marrero TM, Phan L, Bond JA, Alter BP, Bonilla MA, Link D, Newburger PE, Rosenberg PS, Dale DC. Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. <span><span class="ref-journal">Obstet Gynecol. </span>2015;<span class="ref-vol">125</span>:197–203.</span> [<a href="/pmc/articles/PMC4286310/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4286310</span></a>] [<a href="/pubmed/25560125" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25560125</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.boxer.2006.633">Boxer LA, Stein S, Buckley D, Bolyard AA, Dale DC. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. <span><span class="ref-journal">J Pediatr. </span>2006;<span class="ref-vol">148</span>:633–6.</span> [<a href="/pubmed/16737875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16737875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.carlsson.2006.589">Carlsson G, Aprikyan AA, Ericson KG, Stein S, Makaryan V, Dale DC, Nordenskjold M, Fadeel B, Palmblad J, Hentera JI. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. <span><span class="ref-journal">Haematologica. </span>2006;<span class="ref-vol">91</span>:589–95.</span> [<a href="/pubmed/16670064" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16670064</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.carlsson.2004.3355">Carlsson G, Aprikyan AA, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E, Palmblad J, Henter JI, Fadeel B. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:3355–61.</span> [<a href="/pubmed/14764541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14764541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.choi.2010.937">Choi SW, Levine J. Indications for hematopoietic cell transplantation for children with severe congenital neutropenia. <span><span class="ref-journal">Pediatr Transplant. </span>2010;<span class="ref-vol">14</span>:937–9.</span> [<a href="/pubmed/20819181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20819181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.connelly.2012.44">Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. <span><span class="ref-journal">Curr Opin Hematol. </span>2012;<span class="ref-vol">19</span>:44–51.</span> [<a href="/pmc/articles/PMC3291495/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3291495</span></a>] [<a href="/pubmed/22080845" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22080845</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.dale.2017.351">Dale DC. How I manage children with neutropenia. <span><span class="ref-journal">Br J Haematol. </span>2017;<span class="ref-vol">178</span>:351–63.</span> [<a href="/pubmed/28419427" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28419427</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.dale.2017.2290">Dale DC, Bolyard AA, Marrero T, Bonilla MA, Link DC, Newburger P, Shimamura A, Boxer LA, Spiekerman C. Long-term effects of G-CSF therapy in cyclic neutropenia. <span><span class="ref-journal">N Engl J Med. </span>2017;<span class="ref-vol">377</span>:2290–2.</span> [<a href="/pmc/articles/PMC5777346/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5777346</span></a>] [<a href="/pubmed/29211670" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29211670</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.dale.2003.82">Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. <span><span class="ref-journal">Am J Hematol. </span>2003;<span class="ref-vol">72</span>:82–93.</span> [<a href="/pubmed/12555210" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12555210</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.donadieu.2017.557">Donadieu J, Beaupain B, Fenneteau O, Bellann&#x000e9;-Chantelot C. Congenital neutropenia in the era of genomics: classification, diagnosis, and natural history. <span><span class="ref-journal">Br J Haematol. </span>2017;<span class="ref-vol">179</span>:557–74.</span> [<a href="/pubmed/28875503" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28875503</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.fioredda.2015.1885">Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer-Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fischer A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault de Latour R, S&#x000e1;nchez de Toledo Codina J, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C., Severe Aplastic Anemia the Inborn Error, and the Pediatric Disease Working Parties of the European Society for Blood and Bone Marrow Transplantation (EBMT) and Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE).  Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. <span><span class="ref-journal">Blood. </span>2015;<span class="ref-vol">126</span>:1885–92.</span> [<a href="/pubmed/26185129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26185129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.garwicz.2005.38">Garwicz D, Lennartsson A, Jacobsen SE, Gullberg U, Lindmark A. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. <span><span class="ref-journal">Haematologica. </span>2005;<span class="ref-vol">90</span>:38–44.</span> [<a href="/pubmed/15642667" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15642667</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.germeshausen.2010.1207">Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K. Digenic mutations in severe congenital neutropenia. <span><span class="ref-journal">Haematologica. </span>2010;<span class="ref-vol">95</span>:1207–10.</span> [<a href="/pmc/articles/PMC2895047/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2895047</span></a>] [<a href="/pubmed/20220065" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20220065</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.haurie.1998.2629">Haurie C, Dale DC, Mackey MC. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. <span><span class="ref-journal">Blood. </span>1998;<span class="ref-vol">92</span>:2629–40.</span> [<a href="/pubmed/9763544" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9763544</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.horwitz.1999.433">Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">23</span>:433–6.</span> [<a href="/pubmed/10581030" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10581030</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.klein.2007.86">Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, Schaffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:86–92.</span> [<a href="/pubmed/17187068" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17187068</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.klein.2011.399">Klein C. Genetic defects in severe congenital neutropenia: emerging insights into life and death of human neutrophil granulocytes. <span><span class="ref-journal">Annu Rev Immunol. </span>2011;<span class="ref-vol">29</span>:399–413.</span> [<a href="/pubmed/21219176" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21219176</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.k_llner.2006.493">K&#x000f6;llner I, Sodeik B, Schreek S, Heyn H, von Neuhoff N, Germeshausen M, Zeidler C, Kruger M, Schlegelberger B, Welte K, Beger C. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">108</span>:493–500.</span> [<a href="/pubmed/16551967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16551967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.makaryan.2015.3">Makaryan V, Zeidler C, Bolyard AA, Skokowa J, Rodger E, Kelley ML, Boxer LA, Bonilla MA, Newburger PE, Shimamura A, Zhu B, Rosenberg PS, Link DC, Welte K, Dale DC. The diversity of mutations and clinical outcomes for <em>ELANE</em> associated neutropenia. <span><span class="ref-journal">Curr Opin Hematol. </span>2015;<span class="ref-vol">22</span>:3–11.</span> [<a href="/pmc/articles/PMC4380169/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4380169</span></a>] [<a href="/pubmed/25427142" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25427142</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.massullo.2005.3397">Massullo P, Druhan LJ, Bunnell BA, Hunter MG, Robinson JM, Marsh CB, Avalos BR. Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:3397–404.</span> [<a href="/pmc/articles/PMC1895019/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1895019</span></a>] [<a href="/pubmed/15657182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15657182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.newburger.2010.314">Newburger PE, Pindyck TN, Zhu Z, Bolyard AA, Aprikyan AA, Dale DC, Smith GD, Boxer LA. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2010;<span class="ref-vol">55</span>:314–17.</span> [<a href="/pmc/articles/PMC2913300/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2913300</span></a>] [<a href="/pubmed/20582973" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20582973</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.oshima.2010.657">Oshima K, Hanada R, Kobayashi R, Kato K, Nagatoshi Y, Tabuchi K, Kato S., Hematopoietic Stem Cell Transplantation Committee of the Japanese Society of Pediatric Hematology.  Hematopoietic stem cell transplantation in patients with severe congenital neutropenia: an analysis of 18 Japanese cases. <span><span class="ref-journal">Pediatr Transplant. </span>2010;<span class="ref-vol">14</span>:657–63.</span> [<a href="/pubmed/20331518" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20331518</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.palmer.1996.413">Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. <span><span class="ref-journal">Am J Med Genet. </span>1996;<span class="ref-vol">66</span>:413–22.</span> [<a href="/pubmed/8989458" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8989458</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.papadaki.2003.447">Papadaki HA, Eliopoulos GD. The role of apoptosis in the pathophysiology of chronic neutropenias associated with bone marrow failure. <span><span class="ref-journal">Cell Cycle. </span>2003;<span class="ref-vol">2</span>:447–51.</span> [<a href="/pubmed/12963840" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12963840</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.person.2003.308">Person RE, Li FQ, Duan Z, Benson KF, Wechsler J, Papadaki HA, Eliopoulos G, Kaufman C, Bertolone SJ, Nakamoto B, Papayannopoulou T, Grimes HL, Horwitz M. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">34</span>:308–12.</span> [<a href="/pmc/articles/PMC2832179/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2832179</span></a>] [<a href="/pubmed/12778173" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12778173</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.rahbari.2016.126">Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, Dominiczak A, Morris A, Porteous D, Smith B, Stratton MR. UK10K Consortium, Hurles ME. Timing, rates and spectra of human germline mutation. <span><span class="ref-journal">Nat Genet. </span>2016;<span class="ref-vol">48</span>:126–33.</span> [<a href="/pmc/articles/PMC4731925/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4731925</span></a>] [<a href="/pubmed/26656846" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26656846</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.rosenberg.2006.4628">Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC., Severe Chronic Neutropenia International Registry.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4628–35.</span> [<a href="/pmc/articles/PMC1895804/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1895804</span></a>] [<a href="/pubmed/16497969" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16497969</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.rosenberg.2008.210">Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, Aprikyan AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LA, Dale DC. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. <span><span class="ref-journal">Br J Haematol. </span>2008;<span class="ref-vol">140</span>:210–3.</span> [<a href="/pmc/articles/PMC3143022/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3143022</span></a>] [<a href="/pubmed/18028488" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18028488</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.rosenberg.2010.196">Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. <span><span class="ref-journal">Br J Haematol. </span>2010;<span class="ref-vol">150</span>:196–9.</span> [<a href="/pmc/articles/PMC2906693/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2906693</span></a>] [<a href="/pubmed/20456363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20456363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.skokowa.2017.17032">Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. <span><span class="ref-journal">Nat Rev Dis Primers. </span>2017;<span class="ref-vol">3</span>:17032.</span> [<a href="/pmc/articles/PMC5821468/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5821468</span></a>] [<a href="/pubmed/28593997" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28593997</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.thobakgale.2014.50">Thobakgale CF, Ndung'u T. Neutrophil counts in persons of African origin. <span><span class="ref-journal">Curr Opin Hematol. </span>2014;<span class="ref-vol">21</span>:50–7.</span> [<a href="/pubmed/24257098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24257098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.touw.2015.1">Touw IP. Game of clones: the genomic evolution of severe congenital neutropenia. <span><span class="ref-journal">Hematology Am Soc Hematol Educ Program. </span>2015;<span class="ref-vol">2015</span>:1–7.</span> [<a href="/pubmed/26637693" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26637693</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.xia.2009.535">Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC, Link DC. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. <span><span class="ref-journal">Br J Haematol. </span>2009;<span class="ref-vol">147</span>:535–42.</span> [<a href="/pmc/articles/PMC2783282/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2783282</span></a>] [<a href="/pubmed/19775295" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19775295</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.zeidler.2000.490">Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K. Management of Kostmann syndrome in the G-CSF era. <span><span class="ref-journal">Br J Haematol. </span>2000;<span class="ref-vol">109</span>:490–5.</span> [<a href="/pubmed/10886193" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10886193</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="cyclic-n.REF.zeidler.2002.82">Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. <span><span class="ref-journal">Semin Hematol. </span>2002;<span class="ref-vol">39</span>:82–8.</span> [<a href="/pubmed/11957189" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11957189</span></a>]</div></li></ul></div></div><div id="cyclic-n.Chapter_Notes"><h2 id="_cyclic-n_Chapter_Notes_">Chapter Notes</h2><div id="cyclic-n.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>23 August 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>14 July 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 July 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> symbol <i>ELA2</i> replaced with <i>ELANE</i> - HGNC</div></li><li class="half_rhythm"><div>9 September 2008 (cg) Comprehensive update posted live</div></li><li class="half_rhythm"><div>4 January 2007 (cd) Revision: <i>HAX1</i> mutations identified in individuals with <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> neutropenia (Kostmann disease)</div></li><li class="half_rhythm"><div>21 July 2006 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>13 September 2005 (dd) Revision: Genotype-Phenotype Correlations, Surveillance</div></li><li class="half_rhythm"><div>21 May 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>1 October 2003 (cd) Revision: clinical testing availability</div></li><li class="half_rhythm"><div>17 June 2002 (me) Review posted live</div></li><li class="half_rhythm"><div>21 September 2001 (dd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1533</span><span class="label">PMID: <a href="/pubmed/20301705" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301705</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/efemp2-cutis-laxa/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/epb42-spherocytosis/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1533&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1533/?report=reader">PubReader</a></li><li><a href="/books/NBK1533/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1533" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1533" style="display:none" title="Cite this Page"><div class="bk_tt">Dale DC, Makaryan V. ELANE-Related Neutropenia. 2002 Jun 17 [Updated 2018 Aug 23]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1533/pdf/Bookshelf_NBK1533.pdf">PDF version of this page</a> (457K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#cyclic-n.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#cyclic-n.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#cyclic-n.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#cyclic-n.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#cyclic-n.Genetically_Related_Allelic_Dis" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#cyclic-n.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#cyclic-n.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#cyclic-n.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#cyclic-n.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#cyclic-n.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#cyclic-n.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#cyclic-n.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=1991[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ELANE</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488688" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488688" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488688" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488688" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301769" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clinton C, Gazda HT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25879134" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> G6PC3 Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> G6PC3 Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Banka S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301722" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shwachman-Diamond Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Nelson A, Myers K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301357" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chandra S, Bronicki L, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301705" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301705" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04140939a66ee2bad567f4">ELANE-Related Neutropenia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">ELANE-Related Neutropenia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:59:38-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal101&amp;ncbi_phid=CE8816FAE0410E2100000000014F007E&amp;ncbi_session=CE8816FAE0414091_0335SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1533%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1533&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1533/&amp;ncbi_pagename=ELANE-Related Neutropenia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8816FAE0414091_0335SID /projects/books/PBooks@5.22 portal101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>